Skip to main content
Home / Recent Patents on Anti-Cancer Drug Discovery, Volume 5, Number 3
Recent Patents on Anti-Cancer Drug Discovery publishes review articles on recent patents in the field of anti-cancer drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery.

Publisher: Bentham Science Publishers

More about this publication?
Volume 5, Number 3, 2010

Articles

The Use of Temozolomide for the Treatment of Malignant Tumors: Clinical Evidence and Molecular Mechanisms of Action
pp. 172-187(16)
Authors: Bei, Roberto; Marzocchella, Laura; Turriziani, Mario

Favourites:
ADD

Biomarker Assessment in Nutritional Modulation of Oxidative Stress-Induced Cancer Development by Lipid-Related Bioactive Molecules
pp. 188-196(9)
Authors: D. Defago, Maria; A. Soria, Elio

Favourites:
ADD

Insights into the Role of Fc Gamma Receptors (FcγRs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy
pp. 197-204(8)
Authors: Concetti, Fabio; Napolioni, Valerio

Favourites:
ADD

Targeting Cancer Stem Cell Lines as a New Treatment of Human Cancer
pp. 205-218(14)
Authors: Giuffrida, Domenica; M. Rogers, Ian

Favourites:
ADD

Aurora A and B Kinases - Targets of Novel Anticancer Drugs
pp. 219-241(23)
Authors: Libertini, Silvana; Abagnale, Antonella; Passaro, Carmela; Botta, Ginevra; Portella, Giuseppe

Favourites:
ADD

Renal Cell Cancer: State of the Art in Adjuvant Therapy
pp. 242-250(9)
Authors: Buti, Sebastiano; Kraft Rovere, Rodrigo

Favourites:
ADD

Drug Discovery in Ovarian Cancer
pp. 251-260(10)
Authors: M. Chase, Dana; Mathur, Nidhee; S. Tewari, Krishnansu

Favourites:
ADD

Patent Selections:
pp. 261-263(3)
Author: Bentham Science Publishers

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content